Cerebrospinal Fluid (CSF) Analysis and Interpretation in Neurocritical Care for Acute Neurological Condition
DOI:
https://doi.org/10.53089/medula.v14i5.1125Keywords:
acute neurological condition, cerebrospinal fluid analysis, demyelinationAbstract
Cerebrospinal fluid (LCS) is a clear fluid circulating in the intracranial and spinal compartments. Under normal conditions, the composition of LCS remains constant. However, in various neurological disease especially in acute conditions, the composition, quantity and its pressure can be altered. The importance of CSF in the diagnosis of neurological diseases has been enhanced with the development of techniques that allow direct measurement or indirect analysis of CSF composition. These methods not only aid in diagnosis but also in assessing the severity and prognosis of the neurological conditions faced by patients. For instance, measuring glucose levels in CSF can help differentiate between subarachnoid hemorrhage due to an aneurysm and other types of hemorrhagic stroke. By measuring the levels of various LCS components using relevant techniques, diagnosis, severity and prognostication of neurological conditions like infections, subarachnoid hemorrhage, demyelinating conditions, tumor like conditions, etc. can be done. In the context of emergency care, a good understanding of changes in CSF and their relevance to the patient's clinical condition enables doctors to make more accurate decisions regarding management and treatment. Therefore, CSF analysis is crucial not only for initial diagnosis but also for monitoring and assessing the response to therapy. In this review, alterations in LCS components and its relevance to the emergency care physician to help in the management of patients are enumerated.
References
Abdelhak A, et al. Biomarkers of Alzheimer's disease in cerebrospinal fluid: Development of novel technologies and identification of new candidates. J Alzheimers Dis. 2017.
Abdelhak A, et al. Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Apolipoprotein E, Tau protein and amyloid-β protein. CNS Neurol Disord Drug Targets. 2017.
Axelsson M, Sjögren M, Andersen O, Blennow K, Zetterberg H, Lycke J. Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study. Acta Neurol Scand. 2018;138:143–150.
Byrne LM, et al. Neurofilament light chain in neurology: A biomarker of axonal injury. Ann Clin Biochem. 2017.
Carpenter CR, Hussain AM, Ward MJ, Zipfel GJ, Fowler S, Pines JM, et al. Spontaneous Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis Describing the Diagnostic Accuracy of History, Physical Examination, Imaging, and Lumbar Puncture With an Exploration of Test Thresholds. Acad Emerg Med. 2016;23:963–1003.
Claudia R, Carlotta Marzocchi, S Stefania B. Micro RNAs as Biomarkers in Amyotrophic lateral sclerosis. Cells2018;7:219.
Faria AV, et al. Cerebrospinal fluid biomarkers for Parkinson's disease diagnosis and progression. Ther Adv Neurol Disord. 2020.
Fiandaca MS, et al. Cerebrospinal fluid sequestration of plasma extracellular vesicles as a diagnostic tool for CNS disease. J Extracell Vesicles. 2019.
Frigerio I, et al. The potential role of LCS biomarkers for prediction, diagnosis and prognosis of epilepsy. Seizure. 2019.
Kim HJ, et al. Role of Cerebrospinal Fluid Biomarkers in Diagnosis of Acute Meningoencephalitis. J Clin Neurol. 2019.
Kuhle J, et al. Alzheimer's disease biomarkers in cerebrospinal fluid.Ther Adv Neurol Disord. 2017.
Kuhle J, et al. Neurofilament light chain in neurological disorders as a biological marker of neurodegeneration. Biochim Biophys Acta. 2018.
Pan W, Gu W, Nagpal S, Gephart MH, Quake SR. Brain tumor mutations detected in cerebral spinal fluid. Clin Chem. 2015 ;61:514–522.
Pelayo-Terán JM, et al. Cerebrospinal fluid biomarkers to improve diagnosis and predict outcomes in neurological diseases. Front Neurol. 2018.
Vermeulen M, van Gijn J. The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg and Psychiatry. 1990;53: 365–372
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.